PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS (original) (raw)

References

• Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR . 1995 J Biol Chem 270: 27489–27494
• Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M . 1988 Cell 53: 549–554
• Bond JA, Wyllie FS, Rowson J, Radulescu A and Wynford-Thomas D . 1994 Oncogene 9: 281–290
• Bos JL . 1989 Cancer Res 49: 4682–4689
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME . 1999 Cell 96: 857–868
• Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC . 1998 Science 282: 1318–1321
• Cass L, Summers S, Prendergast G, Backer J, Birnbaum M and Meinkoth J . 1999 Mol Cell Biol 19: 5882–5891
• Chung J, Kuo CJ, Crabtree GR and Blenis J . 1992 Cell 69: 1227–1236
• Cobellis G, Missero C and Di Lauro R . 1998 Oncogene 17: 2047–2057
• Cowley S, Paterson H, Kemp P and Marshall CJ . 1994 Cell 77: 841–852
• Cox AD and Der CJ . 1997 BBA 1333: F51–F71
• Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . 1997 Cell 91: 231–241
• Francis-Lang H, Zannini M, De Felice M, Berlingieri MT, Fusco A and Di Lauro R . 1992 Mol Cell Biol 12: 5793–5800
• Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN . 1995 Cell 81: 727–736
• Gallagher AP, Burnett AK, Dowen DT and Darley RL . 1998 Cancer Res 58: 2029–2035
• Gire V and Wynford-Thomas D . 1998 Mol Cell Biol 18: 1611–1621
• Gire V, Marshall C and Wynford-Thomas D . 1999 Oncogene 18: 4819–4832
• Hall-Jackson C, Jones T, Eccles N, Dawson T, Bond J, Gescher A and Wynford-Thomas D . 1998 Br J Cancer 78: 641–651
• Ivan M, Bond JA, Prat M, Comoglio PM and Wynford-Thomas D . 1997 Oncogene 14: 2417–2423
• Joneson T, White MA, Wigler MH and Bar-Sagi D . 1996 Science 271: 810–812
• Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G . 1997 Nature 385: 544–548
• Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH and Der CJ . 1996 Mol Cell Biol 16: 3923–3933
• Leevers SJ and Marshall CJ . 1992 EMBO J 11: 569–574
• Lemoine NR, Mayall ES, Jones T, Sheer D, McDermid S, Kendall-Taylor P and Wynford-Thomas D . 1989a Br J Cancer 60: 897–903
• Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B and Wynford-Thomas D . 1989b Oncogene 4: 159–164
• Lemoine NR, Staddon S, Bond J, Wyllie FS, Shaw JJ and Wynford-Thomas D . 1990 Oncogene 5: 1833–1837
• Marshall CJ . 1996 Curr Biol 8: 197–204
• McCarthy SA, Samuels ML, Pritchard CA, Abraham JA and McMahon M . 1995 Genes Dev 9: 1953–1964
• Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA and Meinkoth JL . 1998 Mol Cell Biol 18: 3718–3726
• Oldham SM, Clark GJ, Gangarosa LM, Coffey RJ and Der CJ . 1996 Proc Natl Acad Sci USA 93: 6924–6928
• Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD and Downward J . 1996 EMBO J 15: 2442–2451
• Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J . 1997 Cell 89: 457–467
• Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . 1997 Cell 88: 593–602
• Suarez HG, du Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R . 1990 Oncogene 5: 565–570
• Treinies I, Paterson HF, Hooper S, Wilson R and Marshall CJ . 1999 Mol Cell Biol 19: 321–329
• Vlahos CJ, Matter WF, Hui KY and Brown RF . 1994 J Biol Chem 269: 5241–5248
• White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M and Wigler MH . 1995 Cell 80: 533–541
• Williams DW, Williams ED and Wynford-Thomas D . 1988 Brit J Cancer 57: 535–539
• Wolthuis RM and Bos JL . 1999 Curr Opin Genet Dev 9: 112–117
• Yang J-J, Kang J-S and Krauss RS . 1998 Mol Cell Biol 18: 2586–2595

Download references